Most Popular
-
1
S. Koreans' happiness rising slowly but surely: presidential panel
-
2
No. of depression patients exceeds 1m in 2022
-
3
Seoul subway fare to rise 12% beginning Saturday
-
4
Races tighten in Seoul as parties battle for Assembly control
-
5
Korean Air to submit new merger plan to ease antitrust concerns
-
6
US calls on China to encourage N. Korea's return to diplomacy
-
7
US House votes to remove Speaker Kevin McCarthy
-
8
6-year-old Uzbek girl found dead in Daegu
-
9
22 Chinese apprehended after illegal entry attempt
-
10
Hyundai Ioniq 7 may start production in July next year
Janssen Korea said Thursday that its schizophrenia medication Invega Sustenna will be covered by national health insurance from Oct. 1.
It means insured patients can buy one month dose of the drug at reduced prices which vary from 12,000 won ($10) to 34,000 won depending on the severity of symptoms.
According to the drug maker, the medicine is proven to ease symptoms of schizophrenia significantly and can be used to lessen the recurrence of schizophrenia symptoms after a long latency.
(baejisook@heraldcorp.com)
It means insured patients can buy one month dose of the drug at reduced prices which vary from 12,000 won ($10) to 34,000 won depending on the severity of symptoms.
According to the drug maker, the medicine is proven to ease symptoms of schizophrenia significantly and can be used to lessen the recurrence of schizophrenia symptoms after a long latency.
(baejisook@heraldcorp.com)
